Diabetes Mellitus, Type 2
Conditions
Brief summary
The Digital Self-Management Program for Medicare Advantage Members with Type 2 Diabetes - Impact on A1c trial is a 26-week long, prospective, intent-to-treat, 2-arm randomized controlled trial that aims to evaluate the impact of the Digital Self-Management Program on A1c levels for individuals with uncontrolled Type 2 diabetes.
Interventions
BEHAVIORALDiabetes Self-Management Program
The Diabetes Self-Management Program is a platform that includes a smart meter, access to coaching 24/7, and a mobile app and website that help members manage their diabetes. The program offers diabetes education and coaching delivered entirely through the smart meter and mobile app or website.
Sponsors
Humana Co.Ltd.
Evidation Health
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Humana Medicare Advantage member * Type 2 diabetes diagnosis * HbA1c levels ≥ 8.0% verified by lab test
Exclusion criteria
* Has any of the following conditions: cancer, chronic heart failure, chronic obstructive pulmonary disease, respiratory failure, chronic kidney disease, end stage renal disease, peripheral vascular disease * Not fluent in English * Humana membership is part of a Full or Global risk arrangement * Enrolled in Humana at Home Care Management
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change from Baseline in A1c at 6 months | Baseline and 6 months | Change in A1c from study baseline to study end |
Countries
United States
Outcome results
None listed